A pituitary-specific enhancer of the POMC gene with preferential activity in corticotrope cells.
about
The selector gene Pax7 dictates alternate pituitary cell fates through its pioneer action on chromatin remodelingCyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease.Dmrt5 controls corticotrope and gonadotrope differentiation in the zebrafish pituitary.Irf8-regulated genomic responses drive pathological inflammation during cerebral malaria.Enhancer-bound LDB1 regulates a corticotrope promoter-pausing repression program.Partially redundant enhancers cooperatively maintain Mammalian pomc expression above a critical functional thresholdAdult pituitary cell maintenance: lineage-specific contribution of self-duplicationRecessive mutations in POLR1C cause a leukodystrophy by impairing biogenesis of RNA polymerase III.Epigenetic changes in fetal hypothalamic energy regulating pathways are associated with maternal undernutrition and twinningPositive selection of co-opted mobile genetic elements in a mammalian gene: If you can't beat them, join themThe macrophage IRF8/IRF1 regulome is required for protection against infections and is associated with chronic inflammationEnhancer turnover and conserved regulatory function in vertebrate evolution.Regulation of organogenesis and stem cell properties by T-box transcription factors.E2F1-mediated human POMC expression in ectopic Cushing's syndrome.Evolution of transcriptional enhancers and animal diversity.Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer.Molecular and functional genetics of the proopiomelanocortin gene, food intake regulation and obesity.EGFR Induces E2F1-Mediated Corticotroph Tumorigenesis.
P2860
Q28511535-CA16798F-7FBC-4A85-BFA6-6B0F4E5D9C3CQ33570330-FFCC23AA-259C-410C-B88A-A20893C4F6A3Q33631780-65EAD8E3-96DD-4494-8677-5FB3293D34D5Q34819713-C7AFE805-D323-4405-9907-1480A7FAE73FQ35062797-951E4D12-4B94-43B7-BC6A-CE7F7A870F72Q35104777-D12CE43F-8010-45ED-892D-9D9B5868A046Q35801540-5E974C82-7132-4FA6-B196-48591A02897CQ35863467-C0C0EEFF-AF1C-45CF-A111-0246B251D56CQ35863756-6562CC30-0FA4-45E5-9C57-AC7D61886E4AQ36194720-55C7486C-5BA0-4850-B4FC-BA47F2BAF8BCQ36767466-2A0EE03B-2C7E-41AF-AE02-C77A8E81D119Q37304879-158C38E1-4CFC-4622-92EA-BFDD2CD53CA9Q38088192-DC8341A2-ECF4-4B87-8995-FA685F5A3936Q42856188-F4542688-0F07-4665-AFCD-F0A7A68F7A9FQ42909090-E1C6A27E-2A28-4BD3-9817-48BE4A3E6C5AQ47104606-A20BC52F-E742-48D1-9435-1468F692A195Q47995304-C4CFE90E-885E-4E1F-9A53-EB45E563D717Q52738992-4709A8BD-F42F-4DD2-9DA8-8A52DF1F8BC8
P2860
A pituitary-specific enhancer of the POMC gene with preferential activity in corticotrope cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A pituitary-specific enhancer ...... ctivity in corticotrope cells.
@ast
A pituitary-specific enhancer ...... ctivity in corticotrope cells.
@en
type
label
A pituitary-specific enhancer ...... ctivity in corticotrope cells.
@ast
A pituitary-specific enhancer ...... ctivity in corticotrope cells.
@en
prefLabel
A pituitary-specific enhancer ...... ctivity in corticotrope cells.
@ast
A pituitary-specific enhancer ...... ctivity in corticotrope cells.
@en
P2093
P2860
P356
P1476
A pituitary-specific enhancer ...... ctivity in corticotrope cells.
@en
P2093
Catherine Couture
Guillaume Sylvain-Drolet
Jacques Drouin
P2860
P304
P356
10.1210/ME.2010-0422
P577
2010-12-30T00:00:00Z